State & Local News
Massachusetts Extends RSV Immunization Window
March 25, 2026
The Massachusetts Department of Public Health has officially extended the recommended administration period for RSV monoclonal antibody immunizations for eligible infants through April 30, 2026. This decision responds to sustained elevated RSV activity beyond the typical season, aiming to enhance protection against severe RSV illness in infants. Procurement professionals and contractors involved in vaccine supply, distribution, and immunization services should note this extension as it impacts demand timing and resource allocation for RSV preventive measures in Massachusetts.
- The extension increases the immunization window by one month, requiring adjustments in vaccine inventory management and distribution schedules.
- Public health agencies and contractors should prepare for continued demand for RSV monoclonal antibodies through the end of April 2026.
- This action highlights the importance of flexible procurement strategies to respond to evolving public health data and seasonal disease patterns.
- Organizations providing outreach and education services may find increased opportunities to support immunization efforts during the extended period.
RSV continues to circulate at meaningful levels later into the spring than we typically see. Public health guidance must reflect the reality of the moment. Extending access to these preventive tools is about matching data and risk with proven measures that can prevent and protect our youngest residents from the most severe effects of this illness.
— Robbie Goldstein, MD, PhD, Public Health Commissioner
Agencies
Massachusetts Department of Public Health